The global Immunomodulators market size is expected to be worth around US$ 333.7 billion by 2030, according to a new report by Vision Research Reports.
The global Immunomodulators market size was valued at US$ 231.7 billion in 2020 and is anticipated to grow at a CAGR of 15.8% during forecast period 2021 to 2030.
The market is anticipated to be predominantly driven by high R&D investments employed by prominent companies, resulting in the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases.
In addition, increasing drug resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with targeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period.
Furthermore, the burgeoning presence of the key players is expected to promote the awareness levels pertaining to the benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period.
In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and Non-Hodgkin’s Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.
The immunosuppressant segment held the largest share of over 50.0% in 2020. The high sales figure is attributable to a wide range of available therapeutics, such as azathioprine, cyclosporine, corticosteroids, and monoclonal antibodies, in this segment. These drugs are used to suppress the immune response to preclude rejection of transplanted organs such as kidney, heart, and liver transplants.
In addition to the presence of a wide product range in this segment, the high applicability of immunosuppressant drugs in the treatment of various autoimmune diseases, such as psoriasis, alopecia areata, lupus, among others, is serving this segment with broader growth prospects. With the surging occurrence of these diseases, the demand likewise, for immunosuppressant drugs, is expected to escalate in the next eight years.
According to statistics published by the National Kidney Foundation in the U.S., 4,761 patients died during the wait for kidney transplants in 2014. This heightened the need for organ transplantation procedures in the U.S., which consequently is boosting the demand for immunosuppressants to lower the incidence of organ transplant rejections.
The other applications segment, including multiple sclerosis, Crohn's disease, rheumatoid arthritis, etc., held a dominant share in 2015 owing to the wide usage of immunomodulators for treatment purposes. Significant untapped opportunities coupled with new drug development initiatives in response to unmet needs and projected product launches for several indications are creating future growth opportunities.
The expected launch of immunomodulatory therapies for the treatment of multiple sclerosis is primarily anticipated to drive the segment growth. For instance, Plegridy & Daclizumab by Biogen, Ocrelizumab by Roche, and Receptos' RPC-1063 & Nerventra by Teva Pharmaceuticals are expected to be made commercially available during the forecast period. These immunomodulators are expected to capture a significant market share in the coming years.
North America dominated the global immunomodulators industry with a share of 38.0%. This dominance can be attributed to the presence of a large diseased population in this region. For instance, in June 2014, according to statistics published by Cleveland Clinic, multiple sclerosis, which constitutes the larger share of the other applications segment, affected approximately 400,000 people in the U.S. alone. The high prevalence level is expected to surge the demand for immunomodulatory therapy in this region.
Hence, increasing demand from end-users for immunomodulator-based treatment and the high therapy cost associated with treating multiple sclerosis using these immunotherapeutic agents are anticipated to drive revenue growth in this segment. The presence of supportive government initiatives and higher awareness levels among end-users are further leading to high demand for immunomodulatory drugs.
Hoffmann-La Roche Ltd., Amgen Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Eli Lilly and Company, Pfizer Inc., and Biogen Inc, among others.
The Middle East and Africa
The Immunomodulators market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Immunomodulators market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Immunomodulators market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunomodulators market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Immunomodulators market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Immunomodulators capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Immunomodulators by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Immunomodulators market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Immunomodulators market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Immunomodulators market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Immunomodulators industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Immunomodulators market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Immunomodulators market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Immunomodulators market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Immunomodulators market. These factors have benefited the growth of the global market for Immunomodulators. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Immunomodulators. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Immunomodulators are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Astaxanthin Market (By Source: Natural, Synthetic; By Product: Dried Algae Meal or Biomass, Oil, Softgel, Liquid, Others; By Application: Nutraceuticals, Cosmetics, Aquaculture and AnimalFeed, Food) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Vascular Grafts Market (By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts; By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease; By Raw Material: Polyester Vascular Grafts, Polytetrafluoroethylene Vascular Grafts) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biotechnology Instruments Market (By Product: Lab Automation Instruments, Life Science Consumables, IVD Instruments, Medical Lasers; By End-use: Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Cone Beam Computed Tomography Market (By Application: Dental Implantology, Oral and Maxillofacial Surgery, Orthodontics, Endodontics, General Dentistry, Temporomandibular Joint (TMJ) Disorders, Periodontics, Forensic Dentistry, Others; By Patient Position: Standing Position, Seated Position, Supine Position; By End-use: Hospitals & Others, Dental Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Aquaculture Vaccines Market (By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines; By Route Of Administration: Oral, Injected, Immersion & Spray; By Application: Bacterial, Viral, Parasitic) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...